Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies-Reference-Cited by-同舟云学术

Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies

Published:2012-09 Issue:9 Volume:18 Page:1628-1633
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Kopylov Uri,Mazor Yoav,Yavzori Miri,Fudim Ella,Katz Lior,Coscas Daniel,Picard Orit,Chowers Yehuda,Eliakim Rami,Ben-Horin Shomron

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference14 articles.

1. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

2. Infliximab Maintenance Therapy for Fistulizing Crohn's Disease

3. Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort

4. Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review

5. Review article: loss of response to anti-TNF treatments in Crohn’s disease

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitorización terapéutica de los fármacos biológicos en la enfermedad inflamatoria intestinal. Documento de Posicionamiento del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU);Gastroenterología y Hepatología;2024-05

2. Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis;Gastroenterología y Hepatología (English Edition);2024-05

3. Development of Antibodies to Ustekinumab Is Associated with Loss of Response in Patients with Inflammatory Bowel Disease;Journal of Clinical Medicine;2023-05-10

4. Effectiveness of golimumab intensification in ulcerative colitis: A multicentric prospective study;Alimentary Pharmacology & Therapeutics;2023-02-27

5. A Systematic Review on the Interest of Drug-tolerant Assay in the Monitoring of Inflammatory Bowel Disease;Journal of Crohn's and Colitis;2022-10-27